<- Go Home

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Market Cap

EUR 14.5B

Volume

121.0K

Cash and Equivalents

EUR 573.8M

EBITDA

EUR 905.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 1.6B

Profit Margin

45.59%

52 Week High

EUR 267.70

52 Week Low

EUR 175.95

Dividend

0.31%

Price / Book Value

N/A

Price / Earnings

N/A

Price / Tangible Book Value

N/A

Enterprise Value

EUR 19.4B

Enterprise Value / EBITDA

20.60

Operating Income

EUR 583.9M

Return on Equity

6.18%

Return on Assets

3.65

Cash and Short Term Investments

EUR 573.8M

Debt

EUR 4.3B

Equity

EUR 3.9B

Revenue

EUR 3.6B

Unlevered FCF

EUR 415.1M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches